Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

25th anniversary of the International Long-QT Syndrome Registry: an ongoing quest to uncover the secrets of long-QT syndrome.

Moss AJ, Schwartz PJ.

Circulation. 2005 Mar 8;111(9):1199-201. Review. No abstract available.

2.
3.
4.

The use of genotype-phenotype correlations in mutation analysis for the long QT syndrome.

Van Langen IM, Birnie E, Alders M, Jongbloed RJ, Le Marec H, Wilde AA.

J Med Genet. 2003 Feb;40(2):141-5. No abstract available.

5.

Molecular genetic basis of sudden cardiac death.

Towbin JA.

Pediatr Clin North Am. 2004 Oct;51(5):1229-55. Review.

PMID:
15331282
6.

Modulating effects of age and gender on the clinical course of long QT syndrome by genotype.

Zareba W, Moss AJ, Locati EH, Lehmann MH, Peterson DR, Hall WJ, Schwartz PJ, Vincent GM, Priori SG, Benhorin J, Towbin JA, Robinson JL, Andrews ML, Napolitano C, Timothy K, Zhang L, Medina A; International Long QT Syndrome Registry.

J Am Coll Cardiol. 2003 Jul 2;42(1):103-9.

7.

Latent genetic backgrounds and molecular pathogenesis in drug-induced long-QT syndrome.

Itoh H, Sakaguchi T, Ding WG, Watanabe E, Watanabe I, Nishio Y, Makiyama T, Ohno S, Akao M, Higashi Y, Zenda N, Kubota T, Mori C, Okajima K, Haruna T, Miyamoto A, Kawamura M, Ishida K, Nagaoka I, Oka Y, Nakazawa Y, Yao T, Jo H, Sugimoto Y, Ashihara T, Hayashi H, Ito M, Imoto K, Matsuura H, Horie M.

Circ Arrhythm Electrophysiol. 2009 Oct;2(5):511-23. doi: 10.1161/CIRCEP.109.862649. Epub 2009 Aug 2.

8.

[Genetic background predisposing the drug-induced long QT syndrome].

Horie M.

Nihon Yakurigaku Zasshi. 2003 Jun;121(6):401-7. Review. Japanese.

PMID:
12835534
9.

The long QT syndromes: genetic basis and clinical implications.

Chiang CE, Roden DM.

J Am Coll Cardiol. 2000 Jul;36(1):1-12. Review.

10.

[DNA-based diagnostics of long QT syndrome].

Berge KE, Haugaa KH, Anfinsen OG, Früh A, Hallerud M, Jonsrud C, Øyen N, Gjesdal K, Amlie JP, Leren TP.

Tidsskr Nor Laegeforen. 2005 Oct 20;125(20):2783-6. Norwegian.

11.

Cardiac arrhythmias: the genetic connection.

Towbin JA.

J Cardiovasc Electrophysiol. 2000 May;11(5):601-2. Review. No abstract available.

PMID:
10826942
12.

Long QT syndrome: a double hit hurts more.

Wilde AA.

Heart Rhythm. 2010 Oct;7(10):1419-20. doi: 10.1016/j.hrthm.2010.06.027. Epub 2010 Jun 22. No abstract available.

PMID:
20601150
13.

Genetic variations of KCNQ1, KCNH2, SCN5A, KCNE1, and KCNE2 in drug-induced long QT syndrome patients.

Paulussen AD, Gilissen RA, Armstrong M, Doevendans PA, Verhasselt P, Smeets HJ, Schulze-Bahr E, Haverkamp W, Breithardt G, Cohen N, Aerssens J.

J Mol Med (Berl). 2004 Mar;82(3):182-8. Epub 2004 Feb 4.

PMID:
14760488
14.

Genotype and severity of long QT syndrome.

Towbin JA, Wang Z, Li H.

Arch Pathol Lab Med. 2001 Jan;125(1):116-21. Review.

PMID:
11151064
15.

Molecular autopsy for sudden unexplained death? Time to discuss pros and cons.

Mazzanti A, Priori SG.

J Cardiovasc Electrophysiol. 2012 Oct;23(10):1099-102. doi: 10.1111/j.1540-8167.2012.02430.x. Epub 2012 Sep 11. No abstract available.

PMID:
22966897
16.

Mutation screening in KCNQ1, HERG, KCNE1, KCNE2 and SCN5A genes in a long QT syndrome family.

Koo SH, Teo WS, Ching CK, Chan SH, Lee EJ.

Ann Acad Med Singapore. 2007 Jun;36(6):394-8.

17.

Spectrum and prevalence of mutations from the first 2,500 consecutive unrelated patients referred for the FAMILION long QT syndrome genetic test.

Kapplinger JD, Tester DJ, Salisbury BA, Carr JL, Harris-Kerr C, Pollevick GD, Wilde AA, Ackerman MJ.

Heart Rhythm. 2009 Sep;6(9):1297-303. doi: 10.1016/j.hrthm.2009.05.021. Epub 2009 Jun 23.

18.

Single nucleotide polymorphism map of five long-QT genes.

Aydin A, Bähring S, Dahm S, Guenther UP, Uhlmann R, Busjahn A, Luft FC.

J Mol Med (Berl). 2005 Feb;83(2):159-65. Epub 2004 Dec 15.

PMID:
15599693
19.

Mutation detection in long QT syndrome: a comprehensive set of primers and PCR conditions.

Syrris P, Murray A, Carter ND, McKenna WM, Jeffery S.

J Med Genet. 2001 Oct;38(10):705-10. No abstract available.

20.

QT interval prolongation and cardiac risk assessment for novel drugs.

Picard S, Lacroix P.

Curr Opin Investig Drugs. 2003 Mar;4(3):303-8. Review.

PMID:
12735231

Supplemental Content

Support Center